FindTrial
Sign In

The relation between HbA1c level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas.

The relation between HbA1c level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas. - The relation between HbA1c level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025284
Enrollment
300
Registered
2017-05-01
Start date
2017-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

sensor insertion

Sponsors

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine
Lead Sponsor
Shinko hospital Nishiwaki municipal hospital Kobe Rosai Hospital Hyogo brain and heart center Rokko island Konan hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 2 diabetic patient taking sulfonylureas HbA1c < 12% outpatient

Exclusion criteria

Exclusion criteria: treated with insulin

Design outcomes

Primary

MeasureTime frame
Association between time of hypoglycemic range(min/day) and levels of HbA1c—

Countries

Japan

Contacts

Public ContactYushi Hirota

Kobe University Hospital Department of Internal Medicine, Division of Diabetes and Endocrinology

hirota@med.kobe-u.ac.jp81-78-382-5860

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026